Dr Stavy · Your care options
Longevity Biomarkers: What They Can and Cannot Tell You
Longevity biomarkers are measurements used to explore health or aspects of ageing. Some measurements support established clinical choices. Others remain research tools. A change in a marker does not by itself prove that a person will live longer or stay healthier. Assessment should connect each planned measurement to a clear, evidence-based choice. [1]

What is a biomarker?
A biomarker is a measurable feature that gives details about a biological process. The word covers very different things, from familiar clinical measurements to experimental combinations of data. Calling something a biomarker does not tell you how correct it is, if it predicts an outcome or if acting on it helps.
Ask what the marker is being used for. It may help diagnose a condition, estimate a risk, monitor treatment or support research. Those uses require different evidence. A test developed to compare groups in a study should not by itself be treated as a precise forecast for one person buying a health assessment.
The TAME biomarker framework describes the difficulty of choosing ageing-related measurements for research. Its talk is useful context for the field, not proof that a commercial panel extends life. A reader should distinguish an interesting scientific measure from a test with a validated role in their own care. [1]
What should I ask before choosing a panel?
Start with the choice you hope the panel will inform. Is there a current medical concern, a prevention question or curiosity about an ageing score? Ask the provider to explain which measurements address that aim and what action would follow each likely result.
Then ask what has been validated. How consistent is the measurement? Does it forecast the outcome being discussed? Is there evidence that changing it changes that outcome? These are separate questions. A strong association in a population does not mean that on aim moving the number will improve health for a person’s.
You should also know what the panel will not answer. A test may leave what is not yet known or produce an unexpected finding that requires a further health review. Ask who will explain those possibilities and if the follow-up is included. A large report has limited value if no one can connect its results to a sound next step.
How do common measurements differ from ageing scores?
Common clinical measurements have specific uses; an ageing score may combine several measurements using a model. Compare them by their aim and evidence, not by how advanced their names sound. The table below illustrates questions to ask. It is not a advised test panel or an instruction to order each item.
| Marker or details | Possible aim | Key limit |
|---|---|---|
| Blood pressure | Inform a cardiovascular risk talk. | A reading needs context and right interpretation. |
| Glucose-related results | Address a glucose or diabetes question. | They do not measure each aspect of metabolic health. |
| Lipid results | Contribute to a cardiovascular assessment. | A single value is not a full personal forecast. |
| Biological-age score | Explore an estimate produced by a given model. | A younger score does not prove longer life. |
| Symptoms and function | Describe what matters in daily life. | A laboratory panel cannot replace this account. |
If you receive a proprietary score, ask for a clear account of the underlying measurements and assumptions. Can another doctor understand the report without access to the vendor's software? Can you obtain the full results? Clear access to your details matters when you want a second opinion or need to relate the report to standard care.
Why is a better number not always a better outcome?
A number can move without showing that a meaningful health outcome has improved. It may change with the conditions of measurement, the method used or an treatment whose long-term effects are unclear. The TAME framework highlights the need to evaluate biomarkers for their planned use rather than assuming they stand in for clinical outcomes. [1]
Ask the provider to name the outcome they expect to improve. Is it a symptom, physical function, a recognised risk or life expectancy? What evidence connects the planned action to that outcome? A chart showing movement in the desired direction does not answer these questions by itself.
This difference is especially key when a programme advises frequent repeat testing. Ask what size or pattern of change would alter care and how ordinary variation is handled. If the answer is always another test or another product, seek a clearer account of the choice process before committing to an long-term expense.
What does natural optimisation mean in practice?
Natural optimisation is a marketing phrase, not a single defined medical treatment. Ask what is in fact planned: a change in daily habits, a supplement, a test or a treatment. Each needs its own aim, evidence and safety talk. The label should not be used to combine many different actions into one presumed benefit.
Explain your priorities and constraints. A plan may be difficult to follow because of work, disability, food access or current treatment. You can ask which element is most key, what alternatives exist and how the plan would be reviewed. A programme should be able to accommodate questions without suggesting that what is not yet known reflects a lack of commitment.
For any product, ask for the exact ingredients, planned use, evidence and cost. Share it with the clinician or pharmacist who knows your medicines. Do not assume that a product sold for longevity has been shown to extend life or that its safety can be inferred from being called natural.
Which health questions belong in a separate pathway?
Use Metabolic Health and Insulin Resistance for insulin resistance and metabolic assessment, and Private Health Screening and Preventive Assessment for the benefits and limits of screening. These pages address choices that a broad longevity label can obscure. If you already have a diagnosed condition, the key treatment and monitoring plan remains a separate task.
For memory or cognitive concerns, use Brain, Sleep and Cognitive Health for Healthy Ageing. A new change in memory is not simply a reason to buy an ageing test. Explain the change to a clinician and ask about the right medical review. If you are feeling well and considering prevention, say that clearly so that the aim of the appointment is understood.
The broader Longevity & Anti-Ageing Medicine in London pathway can help you understand the practice's longevity-related service scope. Ask what the real appointment includes and avoid inferring that each test discussed in an educational article is offered, advised or part of a package. Details about a field is not a personal test order.
How can I compare two longevity offers fairly?
Compare the same features: the question about your care, evidence, total price, interpretation and follow-up. A lower entry price may exclude the review you need, while a larger panel may include measurements with no useful action attached. Ask for a written account so that you can make the comparison calmly.
Weigh up how what is not yet known is presented. A provider should be able to explain a result that is normal, unclear or outside a range without turning each outcome into a reason to buy more. Ask what would count as a reason to stop testing or change direction. That question can reveal if the plan has a defined aim.
Finally, decide what details would be useful to you even if it does not produce a treatment. You may want a clearer view of established risk, help interpreting a past result or a clear account of an advertised claim. A focused talk can be valuable without a promise to slow ageing or a score that appears to quantify your future.
What can I ask about the raw report?
Ask for a copy that shows the name of each test, the date, the units and the lab's range. Keep this with the score or chart. If you seek a second view, the next doctor should be able to see what was measured, not just a green or red badge.
Write your main question at the top: “What should I do with this result?” If no action is advised, ask why. If action is advised, ask what it aims to change in your health. Keep the answer in words you can use again, rather than a set of targets you do not know how to explain.
Common questions
Can a biological-age test tell me how long I will live?
It should not be treated as a personal life-expectancy forecast. Ask what the model was designed to estimate, how it was validated and what remains unknown. A score may be useful in research without establishing that changing it through a commercial programme will extend a person’s life. [1]
Does a younger result prove a treatment worked?
No. A change in a marker is different from proof of better health or longer life. Ask if the change exceeds ordinary measurement variation and if evidence links it to the claimed outcome. The treatment itself needs evaluation; movement in a score cannot show each claimed benefit. [1]
Should I order each marker in the table?
No. The table illustrates different purposes and limits. It is not a advised panel. Start with the question about your care and ask which details would change a choice. Current results may already answer part of it, and some measurements may add little value for your specific situation.
Are natural longevity supplements proven to extend life?
The word natural does not show evidence for longer life or safety for a person’s. Ask about the exact product, ingredients and claimed outcome, and discuss it with a clinician or pharmacist who knows your treatment. Do not treat a general longevity label as proof for a specific treatment.
How often should biomarkers be repeated?
There is no single interval that fits each measurement or person. Ask why a repeat is planned, what change would alter care and who will interpret it. A fixed commercial subscription does not by itself show a clinical need to test, and this page does not set a person’s monitoring schedule.
What should I bring to a longevity assessment?
Bring current results, your medical and treatment history, and the question you want to resolve. If you are comparing a commercial offer, bring the planned panel and claims. Ask how each part relates to a choice and how the plan will fit with any care you already receive.
Make the next step clear
Discuss the options with your usual healthcare professional and confirm the scope of any appointment before booking.
London clinics: Great Portland Street and Chelsea.
Sources and further reading
- A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup; J. Justice, L. Ferrucci, A. Newman, V. Aroda, J. Bahnson, Jasmin Divers, M. Espeland, S. Marcovina, M. Pollak, S. Kritchevsky, N. Barzilai, G. Kuchel; 2018; GeroScience; DOI 10.1007/s11357-018-0042-y. Accessed 30 September 2026.
- NHS: When to call 999. Accessed 30 September 2026.